IFI44L and nasopharyngeal carcinoma: Following the application of miR-9 inhibitors, IFI44L expression was downregulated, indicating that miR-9 can possibley target and regulate IFI44L, thus affecting the relationship between nasopharyngeal carcinoma (NPC) and inflammation (34).